Drone Forge orders six Airbus Flexrotor UAS systems

Guillaume Faury Chief Executive Officer Airbus Airbus SE
Guillaume Faury Chief Executive Officer Airbus - Airbus SE
0Comments

Australian aerospace start-up Drone Forge has signed an agreement with Airbus Helicopters to purchase six Flexrotor uncrewed aerial systems (UAS), comprising 17 aircraft. This marks the largest order for the Flexrotor to date.

The Flexrotor systems will be configured for a range of operations in the Asia-Pacific region, including littoral surveillance, high-altitude inland missions, infrastructure monitoring, and maritime environment assessment.

Each system will feature a heavy fuel engine optimized for maritime operations, enhancing safety and interoperability with naval assets. Starlink connectivity will allow beyond-line-of-sight operations and real-time situational awareness. Additionally, PT-6 imaging technology will provide high-resolution intelligence and surveillance capabilities.

Thomas Symes, CEO of Drone Forge, stated: “We are fully convinced that the Flexrotor, built on a strong engineering heritage, will allow us to tap into new markets with a proven solution where real-time intelligence, mission flexibility and reliability matters.”

Olivier Michalon, Executive Vice President of Global Business at Airbus Helicopters, added: “The landmark order opens a new chapter in our partnership with Drone Forge, reinforcing our shared commitment to delivering cutting-edge crewed-uncrewed teaming capabilities to Asia-Pacific operators.”

This agreement follows a recent Letter of Intent between Airbus and Drone Forge for collaboration on deploying and integrating the Flexrotor UAS operationally.

The Flexrotor is Airbus’ latest addition to its UAS portfolio. It is designed for Vertical Takeoff and Landing (VTOL) missions with a maximum launch weight of 25 kg (55 lbs). It can operate for more than 12-14 hours in typical configurations and integrate various payloads like electro-optical systems and advanced sensors. The system can autonomously launch from land or sea within a minimal footprint area.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.